Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 0.00 0.00%
S&P 500 1,878.61 3.22 0.17%
NASDAQ 4,148.34 21.37 0.52%
Ticker Volume Price Price Delta
STOXX 50 3,166.59 -23.22 -0.73%
FTSE 100 6,682.14 -20.86 -0.31%
DAX 9,457.01 -91.67 -0.96%
Ticker Volume Price Price Delta
NIKKEI 14,429.26 24.27 0.17%
TOPIX 1,169.99 5.09 0.44%
HANG SENG 22,223.53 -339.27 -1.50%

Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.



  Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.

PR Newswire

WAYNE, Pa., Jan. 24, 2013

WAYNE, Pa., Jan. 24, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP
(www.rmclasslaw.com/cases/mapp) is investigating potential claims against the
board of directors of MAP Pharmaceuticals, Inc. ("MAP" or the "Company")
(NASDAQ: MAPP) concerning possible breaches of fiduciary duty and other
violations of law related to the Company's efforts to sell the Company to
Allergan, Inc. in a transaction valued at approximately $958 million.

(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO )

Our investigation concerns possible breaches of fiduciary duty and other
violations of law related to the approval of the transaction by the Company's
board of directors; in particular, whether the Company undertook a fair
process to obtain fair consideration for all shareholders of MAP.  For more
information regarding our investigation, please contact Ryan & Maniskas, LLP
(Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at
rmaniskas@rmclasslaw.com or visit: www.rmclasslaw.com/cases/mapp.         

Under the terms of the proposal, public shareholders of MAP will receive
$25.00 per share in cash for each share of MAP they own.

If you own shares of MAP and would like to learn more about these claims or if
you wish to discuss these matters and have any questions concerning this
announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at
(877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/mapp. 
You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com.  For more
information about class action cases in general, please visit our website:
www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan &
Maniskas, LLP is devoted to protecting the interests of individual and
institutional investors in shareholder actions in state and federal courts
nationwide.

CONTACT: Ryan & Maniskas, LLP
         Richard A. Maniskas, Esquire
         995 Old Eagle School Rd., Suite 311
         Wayne, PA 19087
         877-316-3218
         www.rmclasslaw.com/cases/mapp    
         rmaniskas@rmclasslaw.com

SOURCE Ryan & Maniskas, LLP

Website: http://www.rmclasslaw.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement